DOI: 10.2337/db07-0993
Inhibition of AMP-activated protein kinase protects pancreatic ß-cells from cytokine-mediated apoptosis and CD8+ T cell-induced cytotoxicity
1 Department of Cell Biology, Division of Medicine, Sir Alexander Fleming Building, Imperial College, London, Exhibition Road, London SW7 2AZ, UK Objective: Apoptotic destruction of insulin-producing pancreatic ß-cells is involved in the aetiology of both type 1 and type 2 diabetes. AMP-activated protein kinase (AMPK) is a sensor of cellular energy charge whose sustained activation has recently been implicated in pancreatic ß-cell apoptosis and in islet cell death post-transplantation. Here, we examine the importance of ß-cell AMPK in cytokine-induced apoptosis and in the cytotoxic action of CD8+ T cells.
Research Design and Methods: Clonal MIN6 ß-cells or CD1 mouse pancreatic islets were infected with recombinant adenoviruses encoding enhanced green fluorescent protein (eGFP/Null), constitutively-active AMPK (AMPK CA), or dominant-negative AMPK (AMPK DN) and exposed or not to tumour necrosis factor- Results: Exposure to cytokines, or expression of AMPK CA, induced apoptosis in clonal MIN6 ß-cells and CD1 mouse pancreatic islets. By contrast, over-expression of AMPK DN protected against the proapoptotic effect of these agents, in part by preventing decreases in cellular ATP, and lowered the cytotoxic effect of CD8+ T cells towards NOD mouse islets. Conclusions: Inhibition of AMPK activity enhances islet survival in the face of assault by either cytokines or T cells. AMPK may therefore represent an interesting therapeutic target to suppress immune mediated ß-cell destruction, and may increase the efficacy of islet allografts in Type 1 diabetes.
Correspondence: g.rutter{at}imperial.ac.uk
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||